The flow cytometric outcomes determined that the transferrin-mediated SLNs nanocurcumin has possibly elevated the anticancer activity of curcumin in breast cancer cell lines in in vitro studies compared to the standard group (Mulik et al., 2010). The gene discussed is TF; the disease is breast carcinoma.